You have 9 free searches left this month | for more free features.

Condition

Advanced Solid Cancers (1)

Advanced Solid Cancers Refractory to PD-1 (1)

Angiosarcoma (1)

Urinary Bladder Neoplasms (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

Agenus Inc. (2)

The University of Texas Health Science Center at San Antonio (1)

Collaborator

Intervention

agen1884 (3)

agen2034 (2)

cisplatin (1)

gemcitabine (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

agen1884

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Angiosarcoma Trial (AGEN2034, AGEN1884)

Withdrawn

Angiosarcoma

AGEN2034
AGEN1884

(no location specified)

Dec 21, 2021

Urinary Bladder Tumors Trial in San Antonio (AGEN1884, AGEN2034, Cisplatin)

Active, not recruiting

Urinary Bladder Neoplasms

AGEN1884
+3 more

San Antonio, Texas

Mays Cancer Center

Mar 11, 2022

Advanced Solid Cancers, Advanced Solid Cancers Refractory to PD-1 Trial in United States (AGEN1884)

Completed

Advanced Solid Cancers
Advanced Solid Cancers Refractory to PD-1

AGEN1884

Duarte, California
+10 more

Apr 28, 2022